102 related articles for article (PubMed ID: 11377023)
1. High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2C19 inhibition evaluation.
Bu HZ; Knuth K; Magis L; Teitelbaum P
J Pharm Biomed Anal; 2001 Jun; 25(3-4):437-42. PubMed ID: 11377023
[TBL] [Abstract][Full Text] [Related]
2. High-throughput cytochrome P450 inhibition screening via cassette probe-dosing strategy. IV. Validation of a direct injection on-line guard cartridge extraction/tandem mass spectrometry method for simultaneous CYP3A4, 2D6 and 2E1 inhibition assessment.
Bu HZ; Knuth K; Magis L; Teitelbaum P
Rapid Commun Mass Spectrom; 2000; 14(20):1943-8. PubMed ID: 11013424
[TBL] [Abstract][Full Text] [Related]
3. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
Bu HZ; Magis L; Knuth K; Teitelbaum P
Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
[TBL] [Abstract][Full Text] [Related]
4. High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. II. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2D6 inhibition assessment.
Bu HZ; Magis L; Knuth K; Teitelbaum P
J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):321-6. PubMed ID: 11334347
[TBL] [Abstract][Full Text] [Related]
5. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. V. Validation of a direct injection/on-line guard cartridge extraction--tandem mass spectrometry method for CYP1A2 inhibition assessment.
Bu HZ; Knuth K; Magis L; Teitelbaum P
Eur J Pharm Sci; 2001 Feb; 12(4):447-52. PubMed ID: 11231111
[TBL] [Abstract][Full Text] [Related]
6. High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites.
Bu HZ; Magis L; Knuth K; Teitelbaum P
Rapid Commun Mass Spectrom; 2000; 14(17):1619-24. PubMed ID: 10960916
[TBL] [Abstract][Full Text] [Related]
7. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis.
Yao M; Zhu M; Sinz MW; Zhang H; Humphreys WG; Rodrigues AD; Dai R
J Pharm Biomed Anal; 2007 May; 44(1):211-23. PubMed ID: 17418993
[TBL] [Abstract][Full Text] [Related]
8. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
9. Validation of (-)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomes.
Cai X; Wang RW; Edom RW; Evans DC; Shou M; Rodrigues AD; Liu W; Dean DC; Baillie TA
Drug Metab Dispos; 2004 Jun; 32(6):584-6. PubMed ID: 15155548
[TBL] [Abstract][Full Text] [Related]
10. Automated assessment of time-dependent inhibition of human cytochrome P450 enzymes using liquid chromatography-tandem mass spectrometry analysis.
Atkinson A; Kenny JR; Grime K
Drug Metab Dispos; 2005 Nov; 33(11):1637-47. PubMed ID: 16049126
[TBL] [Abstract][Full Text] [Related]
11. High-throughput radiometric CYP2C19 inhibition assay using tritiated (S)-mephenytoin.
Di Marco A; Cellucci A; Chaudhary A; Fonsi M; Laufer R
Drug Metab Dispos; 2007 Oct; 35(10):1737-43. PubMed ID: 17600081
[TBL] [Abstract][Full Text] [Related]
12. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.
Niwa T; Shiraga T; Takagi A
Biol Pharm Bull; 2005 Sep; 28(9):1805-8. PubMed ID: 16141567
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 3-O-methylfluorescein as a selective fluorometric substrate for CYP2C19 in human liver microsomes.
Sudsakorn S; Skell J; Williams DA; O'Shea TJ; Liu H
Drug Metab Dispos; 2007 Jun; 35(6):841-7. PubMed ID: 17332142
[TBL] [Abstract][Full Text] [Related]
14. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.
Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ
J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717
[TBL] [Abstract][Full Text] [Related]
15. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
[TBL] [Abstract][Full Text] [Related]
16. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.
Voorman RL; Payne NA; Wienkers LC; Hauer MJ; Sanders PE
Drug Metab Dispos; 2001 Jan; 29(1):41-7. PubMed ID: 11124228
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a fast and sensitive UPLC-MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity.
De Bock L; Boussery K; Colin P; De Smet J; T'jollyn H; Van Bocxlaer J
Talanta; 2012 Jan; 89():209-16. PubMed ID: 22284482
[TBL] [Abstract][Full Text] [Related]
18. Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.
Ha-Duong NT; Dijols S; Macherey AC; Goldstein JA; Dansette PM; Mansuy D
Biochemistry; 2001 Oct; 40(40):12112-22. PubMed ID: 11580286
[TBL] [Abstract][Full Text] [Related]
19. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
Mikus G; Schöwel V; Drzewinska M; Rengelshausen J; Ding R; Riedel KD; Burhenne J; Weiss J; Thomsen T; Haefeli WE
Clin Pharmacol Ther; 2006 Aug; 80(2):126-35. PubMed ID: 16890574
[TBL] [Abstract][Full Text] [Related]
20. Quantification of mephenytoin and its metabolites 4'-hydroxymephenytoin and nirvanol in human urine using a simple sample processing method.
Klaassen T; Kasel D; Harlfinger S; Fuhr U
Rapid Commun Mass Spectrom; 2004; 18(15):1675-80. PubMed ID: 15282764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]